These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21227017)

  • 1. The diagnostic value of ultrasound elastography in patients with hepatitis B virus infection: a prospective study.
    Gou YZ; Liu B; Jiang W; Yu HT; Bai XF
    J Int Med Res; 2010; 38(6):2117-25. PubMed ID: 21227017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
    Han Z; Shi Y; Zhu J; Chen Y; Yin F; Xia L; Luo G; Gao Z; Liu J; Jia G; Li C; Zhou X; Han Y
    J Viral Hepat; 2013 Apr; 20 Suppl 1():58-64. PubMed ID: 23458526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.
    Suh DJ; Um SH; Herrmann E; Kim JH; Lee YS; Lee HJ; Lee MS; Lee YJ; Bao W; Lopez P; Lee HC; Avila C; Zeuzem S
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1242-7. PubMed ID: 20028815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
    Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV;
    Gastroenterology; 2009 Feb; 136(2):486-95. PubMed ID: 19027013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Telbivudine treatment on cirrhosis resulting from chronic hepatitis B].
    Liang J; Han T; Xiao SX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):24-7. PubMed ID: 19203447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
    Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
    Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
    Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Yang X; Li J; Zhou L; Liu J; Wang J; Lu W
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):396-403. PubMed ID: 24569820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Telbivudine in the treatment of the chronic B hepatitis].
    Butí MA
    Gastroenterol Hepatol; 2008 Apr; 31(4):258-63. PubMed ID: 18405491
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telbivudine versus lamivudine in patients with chronic hepatitis B.
    Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
    N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis.
    Chan HL; Chen YC; Gane EJ; Sarin SK; Suh DJ; Piratvisuth T; Prabhakar B; Hwang SG; Choudhuri G; Safadi R; Tanwandee T; Chutaputti A; Yurdaydin C; Bao W; Avila C; Trylesinski A
    J Viral Hepat; 2012 Oct; 19(10):732-43. PubMed ID: 22967105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telbivudine in the treatment of chronic hepatitis B.
    Nash K
    Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis.
    Tsai MC; Yu HC; Hung CH; Lee CM; Chiu KW; Lin MT; Tseng PL; Chang KC; Yen YH; Chen CH; Hu TH
    J Gastroenterol Hepatol; 2014 Mar; 29(3):568-75. PubMed ID: 24716215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
    Oliveri F; Coco B; Ciccorossi P; Colombatto P; Romagnoli V; Cherubini B; Bonino F; Brunetto MR
    World J Gastroenterol; 2008 Oct; 14(40):6154-62. PubMed ID: 18985805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telbivudine: a review of its use in compensated chronic hepatitis B.
    McKeage K; Keam SJ
    Drugs; 2010 Oct; 70(14):1857-83. PubMed ID: 20836578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2008 Dec; 103(12):3071-81. PubMed ID: 19086958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients].
    Zhang LJ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):561-3. PubMed ID: 19719910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.